Satsuma Pharmaceuticals, Inc. Business Finance Contracts & Agreements
19 Contracts & Agreements
- Assignment Agreements (5 contracts)
- Investor Rights Agreements (1)
- Loan Agreements (1)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Stock Agreements (7)
- Underwriting Agreements (1)
- Warrant Agreements (2)
- Form of Contingent Value Rights Agreement to be entered into between Shin Nippon Biomedical Laboratories, Ltd. and American Stock Transfer & Trust Company, LLC (Filed With SEC on April 17, 2023)
- Description of Capital Stock (Filed With SEC on March 15, 2022)
- Description of Capital Stock (Filed With SEC on March 25, 2021)
- Registration Rights Agreement to be effective on March 3, 2021 (Filed With SEC on March 1, 2021)
- Securities Purchase Agreement, dated February 26, 2021 (Filed With SEC on March 1, 2021)
- Fourth Amendment to the Amended and Restated Licensing Assignment Agreement, dated May 25, 2020, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Filed With SEC on August 11, 2020)
- Description of Capital Stock (Filed With SEC on March 10, 2020)
- 2019 Employee Stock Purchase Plan (Filed With SEC on September 3, 2019)
- Form of Common Stock Certificate (Filed With SEC on September 3, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 3, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on August 16, 2019)
- Loan and Security Agreement, dated as of October 26, 2018, by and between Silicon Valley Bank and the Company (Filed With SEC on August 16, 2019)
- Third Amendment to the Amended and Restated Licensing and Assignment Agreement, dated October 6, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Filed With SEC on August 16, 2019)
- Second Amendment to Amended and Restated Licensing and Assignment Agreement, dated as of April 27, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Filed With SEC on August 16, 2019)
- First Amendment to Amended and Restated Licensing and Assignment Agreement, dated January 13, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Filed With SEC on August 16, 2019)
- Amended and Restated Licensing and Assignment Agreement, dated December 16, 2016, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical Laboratories, Ltd (Filed With SEC on August 16, 2019)
- Warrant by and between Satsuma Pharmaceuticals, Inc. and Life Science Loans II, LLC (Filed With SEC on August 16, 2019)
- Warrant by and between Satsuma Pharmaceuticals, Inc. and Silicon Valley Bank (Filed With SEC on August 16, 2019)
- Amended and Restated Investors Rights Agreement, dated as of April 23, 2019, by and among Satsuma Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on August 16, 2019)
